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WC studled mltogemc slgnal tmnsductlon m normal and oncogene-transformed 32D cells, a murme hematopolehc cell hne that IS normally 
dependent on mterleukm-3 (IL3) for prohferatlon and survival The formatlon of second messengers was measured m normal cells stimulated with 
IL3, and m cells transfected with foreign growth factor receptor genes and stimulated with appropriate growth factors We also measured the 
steady-state lcvcl of second messengers m 32D cells transformed by e&B, abl, and SK oncogencs which abrogate growth factor requirement We 
found that IL3 stnnulated the formatIon ot dlacylglyccrol independently of mosltol hpld turnover, but concomitantly with Increased turnover of 
phosphatldylchohnc Epldermal growth factor (EGF), and platelct-derived growth factor (PDGF) stimulated the ‘classsal’ turnover of mosltol 
hplds with formahon of dlacylglycerol and c&mm-moblhemg mosltol phosphates Colony stlmulatmg factor-l trigged mosltol lipId turnover, 
although to a much lower extent than EGF and PDGP Transformed cells showed elevated levels of dlacylglycerol together +i/lEh mcr._ased turnover 
of phosphomosmdes and phospllatldylchohne Taken togcthcr thcsc results mdlcatc that different growth factors and oncoprotems associate with 
multiple slgnallmg pathways m 32D cells 
Hematopoletlc ell, Growth factor. Oncogenc, lnosltol hpld, Dlacylglycerol, Phosphatldylchohne, Sgnalhng 
1 INTRODUCTION 
Prohferatlon of cultured cells IS controlled by growth 
factors able to ehc~t the formation of mtracellular mlto- 
gemc signals through different pathways LikewIse, it IS 
commonly accepted that the products of several onco- 
genes interfere with such pathways both mu-mckmg and 
substltutmg for cssentlal components of the slgnalhng 
cascade. Study of the mtlacellular second messengers 
controlling cell plohferatlon and tumollgcnesls 1s partl- 
cularly important m the hematopoletlc tissue, where 
growth, dlfferentlatlon, and leukemogenesls m response 
to growth factors and oncogcnes ale strictly mtcrcon- 
nccted (for review see [l]) However. despite the wlde- 
spread interest m the processes of norm4 hematopoiesls 
and leukemogenesls, ~nost crltlcal mltogemc slgnallmg 
pathways have commonly been studied m cells of dlffcr- 
cnt origin and at various stages of differentiation, thus 
rnakmg It difficult to compare results and to trace d 
unitary picture of how growth factors and oncoprotems 
signal In order to clrcumvene this problem, WC decided 
to study signal transduction m a single hematopoletlc 
ccl1 hne that could be transfected with various growth 
factor receptors OI transformed by oncogencs that ml- 
micked growth factor stmlulatlon To this end, we de- 
clded to utlhze the murmc hematopolctx ccl1 hne dc- 
slgnated 32D. 
C~I/,C\/I~I~~~~~~~~~C~(I~I~/IC~~. M Rtigg cto. Inrt ~u~c ofGcnel,il Pathology. In oldet to establish whether or not common mlto- 
VIJIC Morgdgm SO, 50134 Fmznyc, It& Fa’t (39) (55) 41 6908 gcnic slgnalling p&thwdys were activdted by different 
This Immature, non-tumongeruc myelold lme 1s stnct- 
ly dependent on mterleukm-3 (IL3) for proliferation 
and survival [l] IL3 reqmrement could be abrogated 
either by oncogene-induced transforrnatlon (1 e by 
gents such as er.!& abl, and src[l]) or by mtroductlon 
of foreign growth factor receptor genes followed by 
stimulation with the appropriate growth factor Thus, 
we demonstrated that growth factors as diverse as epl- 
delmal growth factor (EGF), platelet-derived growth 
facto1 (PDGF), and colony stlmulatmg factor-l (CSF- 
1) could sustain 32D cell prohferatlon once the receptor 
gene had been introduced into cells [2-4] Since such a 
vancty of growth factors and oncoprotems could lead 
to a slmllar feature (abrogation of IL3 requirement), we 
reasoned that common signal transducmg elements 
were activated by IL3, EGF, PDGF, CSF-I, and during 
oncogcne-induced transformation However, it is 
known that each one of these factors rehes on different 
signal transducing mechanisms to elicit mltogemc 
responses. EGF and PDGF stimulate the turnover of 
mosltol hplds with formation of dlacylglycerol and 
tnositol phosphates (for review see [5]); CSF-1 seems to 
activate phosphdtidylmositol-3 kmase in macrophages 
and fibroblasts without triggering mosltol hpld hy- 
drolysis [G]; IL3, on the other hand, activates protcm 
klnuse C (PKC) without mcreasmg inositol lipid turn- 
over [7,8]. The mcchanlsm(s) by which IL3 stimulates 
PKC has not been clarified in detail so far 
203 
Volume 291, number 2 FEES LETTERS October 1991 
growth factors and oncogenes m 32D cells, we studied 
mosltol lipid metabohsm, dlacylglycerol and phospha- 
tldic acid formatlon, calcmm moblhzatlon and phos- 
phatldylchohne turnover m response to growth factor 
stnnulation m normal cells as well as the steady-state 
IeveI of these messengers m celis transformed by erbl3, 
a/d, and src oncogenes 
2 MATERIALS AND METHODS 
Radlolsotopcs were from New England Nuclear IL3 and CSF-I 
were from Genzyme, EGF (punfied, receptor grade) was from Collab- 
oratlve Research, PDGF wds from Amgen The wdd-type muPIne 
hematopoietlc cell hne 32D, transfectants expressmg the EGF, u 
PDGF or CSF-I (c-j??s) receptors, and transformants harbormg the 
e&B, ab/, and src oncogencs have been described [t-4,9] The level of 
second messengers (clther at steady-state, or followmg stlmulatlon) 
was determined m cells pretabelted to equlhbrium with 
[‘HJmyomosltot, [‘I-I]- or [‘SC]gtycerot, [“Plortlrophosphate, [me&~/- 
‘HI- or [merlzy/-‘4C]chotlne, followmg labethng and serum-starvation 
procedures previously dcscnbect [IO, I I ] [‘I-I]mosltot phosphates were 
separated by Ion-exchange chromatography or by high-pressure hquld 
chromatography [2-4] [‘HI- or [‘BC]d~acytgtycerot. and [3zP]phospha- 
h&c dcld were separated by thin-layer chromatography (TLC) [IO, 121 
Intraccltular choline metdbohtes (I c phosphochohne and choline 
utnch make up the largest pool of chotrnc metabohtes and are most 
sensltwe to hgdnd stlmutation [ 131) were extracted and separated as 
prcv~ousty dcscrlbcd [tO,t3] Intracellular free Ca?’ levels were 
measured with the fluorescent Ca” mdlcator fura-2 [3] Results of 
second messenger measurement are expressed as fold varlatlon m each 
anatysed metabohte over that wnhout st~mutahon, or over that of 
control (normal) 32D cells when comparmg chfferent transformdnts 
IncorporatIon of radloactlve tabethng m a typIcal cxperlment wds ds 
follows D~acytgtycerol 18417+459 glycerol-contammg phospho- 
hplds 2494147t 104597 (cpmlSE. n=7, of radlodctwlty associated 
with dldcytgtycerot or phosphohplds spots on TLC plate) Inosnot 
phosplrnles 3644_+ 152, inositot-contnmmg phosphohplds 
34151 -t1633 (cpm.!SE, II=/, of radlodchvlty recovered m the total 
mosltot lipid fraction, and of an ahquot (100~1) of the orgdmc phnse 
of modltied Folch extractlon) Intracellular phosphochohnc dnd cho- 
hne 28362309 (cpmtSE, n=S) Phosphatidylcholme 44477i.2175 
(cpm+SE, N%, of rddlOdCliVlty associated with phosphdtldylchohnc 
spot on TLC plate) Phosphandlc acid 506+32, total phosphohplds 
4385?293 (cpm+SE, n=5, of rddlodctlvlty dSsOCldted with phosphdb 
dlc acid or phosphotrplds spots on TLC plates) In order lo rnmlmlzc 
error due to varlablhty m cell number, tdbettmg proccdurc and cx~rdc- 
tlon cfficlency. the rdtios didcytgtycerot/phosphohpids, mositol phos- 
phales/phosphomosltIdcs, phosphochotme/phosphdtldylchohne, and 
phosphatldlc acld/phosphohplds wcrc taken mto dccount III mdking 
cdtcutatlons Thus procedure of result normdh7atlon hds proven rctld- 
bte in d vdrlety of expcrlmentdt condltlons mvolvmg second mcsscngcr 
measurements [IO,] t,t3-IS] 
3. RESULTS 
Although the mltogemc slgnalhng pathway actlvatcd 
by IL3 m 32D cells IS largely unknown, several tndlca- 
tlons point to protcm kmase C as a possible mediator 
of the IL3 effect on plohferdtlon [7,8]. Smce actlvatlon 
of protein kmase C in response to growth factors IS 
behcved to bc achlcved by the generatlon of diacylglycc- 
rol, we rncasurcd dlacylglycerol and other second mcs- 
sengcr fortnatIon III response to different agent\ It is 
worth noting that the IL3 effect was studlcd in wild-type 
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32D cells, whereas the effects of EGF, PDGF, and CSF- 
1 were studied m transfectants expressing their respec- 
tlve receptor [a-41 Control experiments showed that 
transfcctants expressmg foreign growth factor reccptols 
retained their ability to respond to IL3 m the same way 
as wild-type cells did (not shown) Table I shows that 
IL3, EGF, and CSF-1 stimulated the formation of dla- 
cylglycerol to a slmllar extent; the late of dlacylglycerol 
formation was comparable to that reported m fibro- 
blasts stnnulated by potent growth factors [I35 This 
effect was dose- and time-dependent, ime-course expc- 
rlments showed that maximal accumulation of dlacyl- 
glycerol occulted within 10 mm from stlmulatlon 
The ‘classical’ route leadmg to dlacylglycerol forma- 
tion 1s the receptor-medlated hydrolysis of polyphos- 
phomosltldes which yields dlacylglycerol and calclum- 
mobllizmg mosltol polyphosphates Therefore, we mvcs- 
tlgated whether IL3 and other factors activated mosltol 
hpld turnover m 32D cells Table I shows that EGF, 
PDGF, dnd CSF-1 induced formation of mosltol 
phosphates rn 32D cells expressing their respective re- 
ceptor EGF and PDGF stimulated mosltol phosphate 
genelatlon to a similar extent, thus confirming the hy- 
pothesls that both growth factors activate phosphomo- 
sltidase C through a similar mechamsm [16,173 Analy- 
SIS by high-pressure hquld chromatography revealed a 
pattern of mosltol polyphosphate formation consistent 
with previous results obtained with EGF or PDGF stem- 
ulatlon (not shown) Experiments performed m the 
Table I 
Effect of chfferent growth factors on second messenger tormdtlon m 
32D cells cvpressmg foreign growth &tot receptors 
Agonist Cell lrne DAG InsPs p-cho PC PA cd” 
IL3 32D I 54 I 00 I 89 0 70 1 00 90 
EGF EGrR-32D I25 540 IO0 100 293 250 (181) 
CSF- I c-fms-32D I63 I48 I 24 090 ND ND 
PDGF PDGFR-32D ND 641 ND ND ND ND 
32D cctls were Idbelled with [‘“C]- or [‘H]gtyccrol, [‘H]rm~omosltol 
[r~crlr_+‘~C]- or [r,tcrlr,,l-‘H]chotInc. ,md “P ds dcscrlbcd in sccbon 2 
Wild-type 32D cells, or tmnsfcctdnts cuprcs?mg forclgn growth f&or 
rcccptors were then shmutdtcd with the dppropn,ltc growth factor for 
IO rnln Fm,ll conccntrdllon of growth fdccors wrls IL1. 500 U/ml. 
EGF. 500 ng/ml, CSF-I, 500 U/ml PDGF 100 @ml In those cxpcrt- 
mcnts wlicrc mositol phosphates wcrc nicdsurcd. hthlurn chtorldc (20 
mM) wds dddcd durmg incubdtion with ,tgomsl+ Rccults ,lrc cx- 
prc$scd {is fold mcrcdsc over conlrot (tm~tmiutdted) crlts. dnd drc 
nlcdns of dt tc.lst 5 CYpCllrllCnt~, cdLt1 pcrfonncd 111 trrptrcdtc s,inlptcr 
Kcsullb wcrc nornlatlxd for the tout mcorpordhon of radtuamvq 
111 prcculsor phosphohpld\ us dcscrlbcd Intr.lccllutdr lrcc Ca:’ con- 
cenlrntlon wds mcdsurcd by fur&2 and it IS cxp~crrcd ds nM. the 
corrcspolldmg vdtue tor uns~ifiiutdtcd cctts war 89 nM tfi pdrcnttic\cs 
IS indlcdlcd the V~IUC ebt,uncd wtrc~l t.XiF slmul,m.x~ %ds pcrrorfilcd 
111 the presence or I nlM cx~I.mttut.w FGTA AtA~~cv~~r~on~ DAG. 
dldC~t&CIOt. Ill-&, lOkIt IllOCltOt ~IlO~ptla~C~. p-LhC?, InlrdWttUtdr 
phospl~ocholfnc dnd choht~r, PC. pl~~~t~lr~t~dylcl~ol~~~c, PA, pboapha 
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presence of EGTA m the extracellular medium con- 
firmed that stimulation of mosltol lipld turnover was 
independent of extracellular Ca” In 32D cells express- 
mg the c-fins gene (which codes for the CSF-1 receptor), 
CSF-1 stimulated mositol lipid turnover to a much 
lower extent than EGF and PDGF, despite having a 
potent effect on cell proliferation [4] Analogous experi- 
ments performed m NII-I/3T3 fibroblasts transfected 
with c-fbzs gave identical results (not shown) These 
results sustain the hypothesis that CSF-1 does not act!- 
vate the ‘classIcal’ turnover of mositol hplds [6], even 
though a small, but slgmficantly reproducible. effect on 
mosltol phosphate formatlon could be observed IL3, 
on the other hand, consistently falled to stnnulate mosl- 
tol phosphate generation both m wild-type cells, or m 
transfectants expressing foreign receptors (Table I) 
Consistent with the results on mosltol lipid turnover, 
EGF induced a rapld rise m free CaZC from intracellular 
stores, whereas IL3 did not affect mtrdcellular free Ca* 
concentration neither in the presence nor m the absence 
of extracellular Ca” (Table I) Taken together these 
results mdlcate that dlacylglycerol formation observed 
m response to IL3 could be ascr:bed to sources other 
than mosltol lipid hydrolysis 
Beside the turnover of mosltol lipids, dlacylglycerol 
which activates protein kmase C can be formed through 
at least two other slgnalhng pathways turnover of 
phosphatldylcholme (fol review see [ lS]), and synthesis 
de novo [19,20] Stimulation of the turnover of phos- 
phatldyleholme m response to IL3 has been previously 
demonstrated in a mast/megdkaryocytc cl1 line [21] In 
order to assess whether phosphatidylcholme turnover 
was a general response of hematopoietlc cells to IL3, we 
decided to study the effect of IL3 on the agonist-mduced 
intracellular accumulation of choline dnd phosphocho- 
hne, and on the decrease of phosphat~dylcholme. Table 
1 shows that IL3 stimulated the formation of water- 
soluble choline metabohtes togethel with a sigmficant 
decrease of the precursor phospholipld. I e phosphatl- 
dylcholme Identical results wele obtamed In 32D cells 
tlansfected with the EGF receptor, I e In cells dble to 
couple with mosltol hpld turnover, thus mdlcating that 
phospholnosltlde and phosphatldylcholme turnover m 
response to dlffeient growth factors operated mdepen- 
dently in the same ccl1 line Taken togethel these data 
led to the conclusion that IL3 stimuidted dldcylglycerol 
gcncratlon in 32D cells by means of mcrc,tsed phospha- 
tldylchohnc turnover. therefore, IL3-Induced mctdbo- 
lism of phobphatldylchollnc appcas to be a general 
phcnonwnon in tieimtopoletic ccl1 lines as well ds in 
other ccl1 types stunulatcd by app~ opt late g1 owth 
factots [13] 
CSF-1 IS known to hnutate phosphatldylcholinc hy- 
dlolysts 111 monocytes without trlggelmg the turnover of 
inositol lipids [22]. Smce we had obse~vcd a different 
pattern (i.e. stnnul&on of Inositol lqxd metabohm) in 
32D ccll$ tt.msfcctcd with rhc c-/rrra gcnc. WC wondcted 
whether CSF-1 triggered phosphattdylcholme hydroly- 
sis m 32D cells made to express Its receptor Table I 
shows that CSF-1 also stimulated accumulation of cho- 
hne metabohtes and hydrolysis of phosphatidylchohne, 
albeit to a lower extent than IL3 As expected, addition 
of CSF-1 to wild-type 32D cells failed to stimulate both 
slgnalhng pathways (not shown) These data indicate 
that CSF-I was able to couple both to mositol lipid and 
phosphatldylshohne turnover m 32D cells expressing 
the c-ftns gene 
EGF, on the other hand, did not seem to stimulate 
phosphatldylchohne turnover m 32D cells made to ex- 
press its receptor, thus identifying two separate path- 
ways for diacylglycerol formation m response to ago- 
nists m 32D cells. In addltlon to the hydrolysis of poly- 
phosphoinosltldes, EGF stimulated the formatlon of 
phosphatldlc acid (Table I) which can be consldered a 
second messenger able to stimulate cell growth [23,24]. 
Phosphatldlc acid can be formed either from phospho- 
rylation of diacylglycerol, or from synthesis de novo, 
thus being the precursor of dlacylglycerol m phospho- 
lipid synthesis [l&19] IL3, despite stnnulatmg dlacyl- 
glycerol formation, did not Induce phosphatldlc acid 
productlon (Table I), thus suggesting that dlacylglyce- 
lo1 folmed m response to different growth factors un- 
derwent different metabolic processing In fact, a pecul- 
iar action of EGF on selective mcolporatlon of phos- 
phate mto phosphatidlc acid has been observed m other 
cell systems [25] The pathway of de nova synthesis of 
diacylglycerol was also investigated by non-cqudibrmm 
labelhng of 1~11s with ladloactlve precursors as de- 
scribed [19,20] None of the growth factors tested, how- 
ever, seemed to slgmficantly stimulate this pathway in 
32D cells (not shown) 
Cell tlansfolmation by oncogenes that code for pro- 
Table II 
Steddy-mtc levels of phosphochohne, mosrtol phosphates, and dmyl- 
glymol m 32D cells trmsformed by ODE, trD/, or SIC oncogenes 
- 
32D cell lme p-cl10 InsPs DAG 
447 3 85 1 86 
2 82 3 47 2 19 
5 91 I 52 ND 
- 
Cell cullurcs wcrc labcllcd to cquhbrlm wt~h [nwh I-“C]cholme, 
[‘H]rrl\omosltol, or [“CJglyccrol. 111 SerLmwontdmmg mcdwn After 
tddloldbcllmg, Lulrulcs wcrc wdshcd and mdmt~wicd for 4 h in scrum- 
flee mcdwn, ,Iftcr which the mcdn.nn MS rcmovcd and cells mcubrtcd 
for I h III 35.mm dlshcs contming I ml of strum-free mcdnnn In 
cq~.~~rlmms dcs~gucd for mcaurutg I~FPs formdtlon. Itthum rhlorlde 
(20 mM) wds prcscnt dut 111g the liml mcubatton Ititrd~clluldr phos- 
plloCllollllc (p.cl10). total lllosltdl phosphdtc\ (IllSPS). dlld dldCyIgIyCc- 
tol (DAG) wcrc outrxtcd diid mcdwcd ds dcrwbcd 111 wction 2 
VdhCS obldlllcd f-01 CdCh IllCtdbClhtC wrc Iiominlwd ror the dlllOUllt 
or tddlo.lCtwy ds~oattcd uih the precursor phosphohprd Data arc 
CxplC55Cd dS fold lllClCdIC OVEI colltro~ (I C llorllid~ 328 Cch wrc 
tdk :II d5 I 00). und .lrc II~C.II~\ ot .rt Icdql three dctcrrnmdtlon’i ND. 
not drlcmhxl 
20.5 
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tems mvolved m mltogemc slgnallmg has been assocla- 
ted with multifaceted alterations of mtracellular second 
messengers (for review see [26]) Complex changes m- 
volvmg mosltol lipid metabohsm and phosphatldylcho- 
hne turnover m cells transformed by a variety of onco- 
genes have been reported [26-2.81 However, the major- 
rty of studies on the silbJ%ct dealt with mouse fibroblast 
cell lines [27,28], I e cell hnes that mostly utlhze mosltol 
hpld turnover for slgnalhng m response to potent 
growth factors such as PDGF, bombesm, or serum. The 
case of kematopolet!c ells IS different, since most natur- 
ally-occurrmg hematopoletlc growth factors do not stem- 
ulate the hydrolysis of phosphomosltldes Thus, hav- 
mg assessed that wild-type 32D cells did not normally 
use the phosphomosltlde pathway, we wondered how 
transfotmatlon by oncogenes that abrogated IL3 de- 
pendency could affect the level of those second messen- 
gers whose generatlon had been observed in response to 
growth factors that also abrogated EL3 dependency 
once the cells were made to express the appropriate 
receptor. To this end. we decided to study transfor- 
mants harbormg the erbF3, abl, or WC oncogenes, 1 e 
transforrmng genes whose products substituted for the 
activated EGF receptor, or tyrosme kmases, respec- 
tively 
Normal and transformed cultures were pre-labelled 
to equlhbrlum with radioactive glycerol, choline, and 
mosltol; afterwards, they were serum-starved for 4 h 
followed by 1 h final incubation m serum-free medium. 
Table II shows that all transformants had elevated 
levels of water-soluble phosphocholme, mosltol phos- 
phates, and dlacylglycerol over that of control 32D 
cells The turnover of mosltol lip& was measured both 
m the presence and m the absence of hthlum during the 
final 1 h incubation, m the absence of lithium, values 
were significantly lower than m its presence. although 
they remained higher than those of control cells These 
data indicate that transformation by crbl3, ubl, and SW 
oncogenes constltutively incredsed the turnover of ino- 
sltol liplds and phosphatldylcholine, thus mlmlckmg the 
effect of growth factors that exploit such second mes- 
senger systems to convey mltogenic signals. 
4 DISCUSSION 
Control of ccl1 prohferatlon IS excrtcd by plotems 
able to stimulate or inhibit ccl1 growth. and ‘I number 
of mtraccllular slgnallmg pathways have been dc- 
scribed. Knowlcdgc of the signals controlhng rnyclold 
ccl1 prollfcrcratlon ay prove important III undcrstunding 
the niechnism of normal hcmatopolcs~s as well ds the 
escape from growth f&or rcyulrcincnt thdt Icads to 
lcukemlc transformatmn. OUI rcaults showed that the 
myclord 32D cell lint was able to utih~e diffcrcnt second 
nwssenycr systems iti rcsponsc to physhq+xl iurd foi- 
ciyn growth fiietors It qpcnrs tiiut the control on the 
type of second mcssciigcr pruduccd was wired nt tltr 
level of growth factor receptor Thus, hematopoletic 
cells made to express the EGF or the cy. PDGF receptor 
responded to such growth factors m the same way as 
eplthehal or mesenchymal cells did when stimulated by 
EGF or PDGF respectively [5,26] IL3, on the other 
hand, activated the turnover of phosphatldylcholme sl- 
nularly to the extent m a mast/megakaryocyte cell lme 
[21], thus substantiating the hypothesis that phosphatl- 
dylchohne turnover m response to mterleukms was a 
common feature of hematopoletlc cells [29] 
The effect of CSF-1 on slgnalhng m c--ns-expressmg 
cells was rather mtrigumg m fact, earher studies report- 
ed that CSF-I was not able to stimulate the ‘classicdl’ 
turnover of mositol hplds either m macrophages that 
endogenously express its receptor or m BALWc fibro- 
blasts made to express the receptor [6] However, over- 
expression of CSF-1 receptor m 32D cells and m NM/ 
3T3 fibroblasts [4] led us to observe a small, but slgnifi- 
cantly reproducible, accumulation of rnosltol phos- 
phates m response to the factor (Table I). Several ex- 
planations may account for this phenomenon The 
CSF-I receptor gene product shares structural and se- 
quence slmllarlties with the PDGF receptor however, 
while tyrosme kmase domains are very similar, their 
kmase insert domains are highly unrelated both m 
predicted sequence and length In a recent study we 
demonstrated that insertion of the c-ftns kmasc insert 
domain could reconstitute brochemlcal and bIological 
respor,ses to PDGF, m 32D cells expressmg a deletion 
mutant of the c1 PDGF receptor lackmg the original 
kmase insert [9] Using a similar approach we also dem- 
onstrated that tyrosmc mutations wlthm the cx PDGF 
receptor kmasc insert domain could abi ogate receptor- 
associated phosphatldylmosltol-3 kmasc activity wlth- 
out affectmg phosphomosltide turnover and mltogemc 
and chemotactlc signal transduction [30] These results 
support the consrderatlon that stmlulation of mosltol 
lipid metabohsm appears to be a mandatory event m 
PDGF slgnalhng [30,31] Therefore, it IS proposed that 
the overexpiessed c-fins product might Interact with, 
nnd stimulate with low efficiency, the PDGF slgnalling 
pathway, thus leading to mosltol phosphate formatlon 
Future studies will detcrmme whether the phosphoino- 
sltldase C expressed m 32D cells 1s a good substrate for 
CSF-1 receptor tyrosme kinasc In addition to the hy- 
drolysis of phosphomosltldes. CSF-1 also stmiuldted 
the turnover of phosphatidylcholme: thcsc results <trc 
consistent with a prcv~ous obscrvntlon made m human 
monocytcs [22]. thus indiratmg that phosphatidyl- 
cholme turnover m ~csponsc to CSF-I was a fenturc 
shared by different hcmatopoictic cell Imcs From these 
tc\ults, however, WC cannot conclude whether CSF-I 
signalled through both p&hways, or whether stnnuln- 
tion of inosltol lipid turnover was Just an epiphcno- 
menon due to ovcrcxptcrsion of the leccptol. 
Finally, transformution by sncogcnes the products of 
which mtnmkcd gowth f’ilctor sipnulllnp. at different 
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levels, was associated with elevated turnover of mosltol 
lipids and phosphatldylcholme; these results suggest 
that the same pathways activated by growth factors 
were constltutlvely operatmg durmg transformation. It 
IS worth noting that these results were obtained m a 
hematopolctlc cell lme which IS devoid of growth factor 
receptors coupling to mositol hpld turnover; therefore, 
alteration of phosphomosltlde metabohsm could be 
ascribed to a direct effect of oncogene-induced transfor- 
mation, ruhng out at the same time “cross-talk’ between 
endogenous receptors couplmg with lnosltol lipid turn- 
over and oncoprotems Furthermore, 32D cells pro- 
vided an example of transformed cells utdizmg both 
phosphomosltlde and phosphatldylcholmc turnover, 
these results are at vanance with those obtained m 3T3 
fibroblasts, where the two pathways appeared mutually 
exclusive [10,11,20,26] From what 1s reported above, it 
follows that the maJo pomt of convergence of the dif- 
ferent slgnallmg pathways activated In response to 
growth factors, and durmg transformatlon, was dlacyl- 
glycerol formation, and, therefore, protem kmase C ac- 
tivation. 
In conclusion, WC assessed that different slgnallmg 
pathways were avallablc m myeloid 32D cells to control 
prolife! atlon, the type of mltogemc slgnallmg pathway 
was dependent on receptor explesslon Transformation 
by e&B, aDI, and SK oncogenes was associated with 
complex alterations of signal transduction mvolvmg 
both mosltol hpld and phosphatldylchohne turnover 
Our data suggest that dlacylglycerol formatlon, and 
protein kmase C activation, could play a prominent role 
m the abrogation of growth factor requirement m mye- 
lold cells. 
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